Dow Agro plans ‘major’ expansion announcement
Local Dow Chemical subsidiary expects to launch five new biotech products by 2012.
Health Care & Insurance
Articles
Lilly, Transition Therapeutics make diabetes deal
Drug developer Transition Therapeutics Inc. said Wednesday that it will pay $1 million to license a group of potential diabetes
drugs from Eli Lilly and Co.
IU cancer center names new director
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center’s founding director, who died of cancer in February
2009.
Consumer group sues Anthem over policy changes
A consumer watchdog group filed a lawsuit Monday against WellPoint’s California subsidiary on behalf of policyholders, claiming
they were pushed to take coverage with fewer benefits and higher deductibles.
State health commissioner leaving for CDC
Dr. Judy Monroe, after five years as Indiana’s public health leader, will spearhead communication between federal and state
health agencies.
Conseco shares fall after dip in fourth-quarter profits
Carmel-based insurer swings to a profit, but earnings from operations decline.
WellPoint records subpoened in California probe
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
Study: Hospital clout spurs higher Calif. health costs
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.
Conseco’s quarterly profit trimmed by legal costs
Carmel-based insurer Conseco Inc. has been profitable for four straight quarters.
House approves smoking ban in public places
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse
racing venues.
WellPoint CEO blames health costs for hikes
Amid attacks from Democrats over high executive salaries, Angela Braly testified in Washington, D.C., on Wednesday that big
insurance-premium increases are
the result of growing price tags for hospital care and pharmaceuticals.
WellPoint testimony drops green flag on health reform restart
CEO Angela Braly is defending individual premium hikes one day before Obama's summit to debate his new reform proposal
with Republicans.
Medco profit rises as mail-order generics business grows
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
WellPoint to face questioning over rate hike
Executives are scheduled to testify Tuesday before a California legislative committee and on Wednesday before a U.S. House
of Representatives committee about big premium increases.
Lilly, Merck, Pfizer starting research center
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
California regulator finds Anthem Blue Cross violations
California’s insurance regulator said Monday his office has found more than 700 violations by the state’s largest for-profit
health insurer, a subsidiary of Indianapolis-based WellPoint.
WellPoint gets tax delay in Obama health plan
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
Obama endorses new taxes, more drugmaker fees
Obama, seeking to break an impasse over health-care legislation, proposes a plan that includes the first Medicare tax on unearned
income such as capital gains and higher fees on drugmakers.
Insurers warn of problems with federal regulator
President Obama’s latest push for a health care overhaul could drive health plans around the country into insolvency, according
to an insurance trade group.
A closer look at WellPoint’s health insurance profits
At the heart of the debate is the question of what should be a fair profit for health insurers. WellPoint CEO Angela Braly
will likely be grilled on the issue when she appears at a Congressional hearing Wednesday.